Source document or public record

FDA 510(k) K232092 — Great Basin Toxigenic C. difficile Direct Test (CDF2)

FDA 510(k) index record K232092. Device: Great Basin Toxigenic C. difficile Direct Test (CDF2). Applicant as listed: Vela Operations USA. Decision date: 2023-11-14.

OtherU.S. Food and Drug Administration (FDA)2023-11-14

Source

"device_name": "Great Basin Toxigenic C. difficile Direct Test (CDF2)"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K232092.

Device name: Great Basin Toxigenic C. difficile Direct Test (CDF2). Applicant as listed: Vela Operations USA.

Decision date: 2023-11-14. Decision wording: Substantially Equivalent.

Product code: OZN. Regulation: 21 CFR 866.3130. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.